Is Adc Therapeutics SA (NYSE: ADCT) Poised For Further Gains At A 92.74% Distance From The Low?
Adc Therapeutics SA (NYSE:ADCT)’s traded shares stood at 1.23 million during the last session, with the company’s beta value hitting 1.70. At the close of